Revolution Medicines, Inc.
RVMD
$77.12
$1.812.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -960.98M | -812.06M | -697.51M | -600.09M | -567.06M |
| Total Depreciation and Amortization | 14.14M | 12.68M | 11.68M | 10.72M | 10.20M |
| Total Amortization of Deferred Charges | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Other Non-Cash Items | 87.35M | 62.88M | 43.36M | 30.43M | 36.52M |
| Change in Net Operating Assets | 96.60M | 50.49M | 50.06M | 406.00K | -20.46M |
| Cash from Operations | -761.79M | -684.90M | -591.31M | -557.44M | -539.71M |
| Capital Expenditure | -15.29M | -15.46M | -10.41M | -10.31M | -11.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -334.44M | -380.59M | -311.97M | -544.09M | -530.49M |
| Cash from Investing | -349.73M | -396.05M | -322.38M | -554.39M | -541.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 789.72M | 862.87M | 863.79M | 863.71M | 88.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -4.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 339.95M | 345.69M | 95.69M | 95.71M | 840.83M |
| Cash from Financing | 1.13B | 1.21B | 959.48M | 959.41M | 924.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.15M | 127.61M | 45.79M | -152.42M | -156.64M |